Trgovina Eyenovia, Inc. - EYEN CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | - | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 1.50-3.34 |
Povprečni obseg (10 dni) | 103.72K |
Povprečni obseg (3 meseci) | 4.11M |
Tržna kapitalizacija | 107.64M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 36.12M |
Prihodki | 10.00M |
EPS | -0.56 |
Dividenda (donosnost v %) | N/A |
Beta | 1.67 |
Datum naslednjega zaslužka | Mar 30, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|
Eyenovia, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 14 | 2 | 0 | 0 | 0 |
Prihodki | 14 | 2 | 0 | ||
Celotni odhodki iz poslovanja | 26.4403 | 21.7892 | 21.3085 | 17.2564 | 5.13237 |
Celotna prodaja/splošni/upravni stroški Odhodki | 10.7842 | 7.69759 | 7.20051 | 6.13618 | 1.31564 |
Raziskave in razvoj | 14.2979 | 13.1962 | 14.0927 | 11.1011 | 3.79127 |
Depreciation / Amortization | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
Prihodki iz poslovanja | -12.4403 | -19.7892 | -21.3085 | -17.2564 | -5.13237 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.38524 | 0.00936 | 0.15179 | 0.00334 | 0.00238 |
Čisti dobiček pred obdavčitvijo | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Čisti dobiček po davkih | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Čisti dobiček pred dodatnimi postavkami | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Čisti dobiček | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Prilagoditev za redčenje | |||||
Popravljen čisti dobiček | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Popravljene ponderirane povprečne delnice | 26.3241 | 21.0547 | 14.3497 | 9.47671 | 9.93677 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.48543 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
Dividends per Share - Common Stock Primary Issue | |||||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.50303 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
Skupaj izredne postavke | 0 | ||||
Celotni stroški prihodkov | 1.6 | 0.8 | |||
Bruto dobiček | 12.4 | 1.2 | |||
Drugo, neto | 0.04718 | 0.01 | |||
Nenavadni odhodki (prihodki) | -0.46335 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 10 | 0 |
Prihodki | 0 | 0 | 0 | 10 | 0 |
Celotni stroški prihodkov | 0 | 0 | 0 | 0 | 0 |
Bruto dobiček | 0 | 0 | 0 | 10 | 0 |
Celotni odhodki iz poslovanja | 7.23023 | 7.12146 | 7.18755 | 6.88673 | 5.46171 |
Celotna prodaja/splošni/upravni stroški Odhodki | 3.35335 | 3.53459 | 3.47497 | 3.7115 | 2.373 |
Raziskave in razvoj | 3.87688 | 3.58687 | 3.71258 | 3.17523 | 3.55207 |
Prihodki iz poslovanja | -7.23023 | -7.12146 | -7.18755 | 3.11327 | -5.46171 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.14905 | -0.15102 | -0.14505 | -0.18519 | -0.11861 |
Drugo, neto | 0.07028 | 0.03338 | -0.00707 | 0.05519 | 0.01173 |
Čisti dobiček pred obdavčitvijo | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Čisti dobiček po davkih | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Čisti dobiček pred dodatnimi postavkami | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Čisti dobiček | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Popravljen čisti dobiček | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
Popravljene ponderirane povprečne delnice | 34.6318 | 33.6449 | 30.0082 | 27.977 | 26.0535 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.21374 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.23152 |
Nenavadni odhodki (prihodki) | 0 | 0 | -0.46335 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 29.8769 | 33.3913 | 14.3493 | 19.861 | 5.28666 |
Denarna sredstva in kratkoročne naložbe | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
Cash | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
Prepaid Expenses | 0.38663 | 0.2898 | 0.07737 | 0.13276 | 0.03715 |
Total Assets | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
Property/Plant/Equipment, Total - Net | 1.27123 | 0.39638 | 0.23054 | 0.03674 | 0.02796 |
Property/Plant/Equipment, Total - Gross | 1.59963 | 0.57329 | 0.31203 | 0.10289 | 0.07498 |
Accumulated Depreciation, Total | -0.32841 | -0.17691 | -0.08149 | -0.06615 | -0.04702 |
Total Current Liabilities | 11.1725 | 18.1984 | 2.91166 | 3.09884 | 0.55265 |
Accounts Payable | 1.6141 | 1.46167 | 1.54136 | 1.50952 | 0.24638 |
Accrued Expenses | 2.32693 | 2.57974 | 1.31332 | 1.56769 | 0.29529 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.08109 | 14.0594 | 0.05698 | 0.02163 | 0.01098 |
Total Liabilities | 11.1924 | 18.6029 | 2.95701 | 3.14043 | 0.55265 |
Total Long Term Debt | 0 | 0.36581 | 0 | 0 | 0 |
Other Liabilities, Total | 0.01995 | 0.03868 | 0.04535 | 0.04158 | 0 |
Total Equity | 20.4666 | 15.3039 | 11.7406 | 16.8751 | 5.09067 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Preferred Stock - Non Redeemable, Net | 0.00046 | ||||
Common Stock | 0.00284 | 0.0025 | 0.00171 | 0.00115 | 0.00026 |
Additional Paid-In Capital | 110.683 | 92.7423 | 69.41 | 53.3882 | 24.3511 |
Retained Earnings (Accumulated Deficit) | -90.2193 | -77.4409 | -57.6711 | -36.5143 | -19.2612 |
Total Liabilities & Shareholders’ Equity | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
Total Common Shares Outstanding | 28.4266 | 24.9786 | 17.1007 | 11.469 | 9.93677 |
Other Long Term Assets, Total | 0.51098 | 0.11904 | 0.1178 | 0.1178 | 0.3287 |
Celotne terjatve, neto | 2.14885 | 3.11798 | 0.09523 | ||
Other Current Assets, Total | 7.87953 | 1.61173 | 0.02408 | ||
Current Port. of LT Debt/Capital Leases | 7.15037 | 0.09754 | |||
Long Term Debt | 0 | 0.36581 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 30.3986 | 29.8769 | 23.4593 | 29.495 | 28.0252 |
Denarna sredstva in kratkoročne naložbe | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
Cash | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
Celotne terjatve, neto | 1.85222 | 2.14885 | 1.25767 | 1.17134 | 1.17891 |
Prepaid Expenses | 1.79656 | 0.38663 | 0.77768 | 1.04895 | 1.089 |
Other Current Assets, Total | 0.03358 | 7.87953 | 7.92312 | 0.09787 | 0.85025 |
Total Assets | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
Property/Plant/Equipment, Total - Net | 1.37036 | 1.27123 | 1.4132 | 0.96888 | 0.70742 |
Other Long Term Assets, Total | 8.41907 | 0.51098 | 0.11904 | 0.11904 | 0.11904 |
Total Current Liabilities | 10.3788 | 11.1725 | 20.7194 | 14.5598 | 16.3656 |
Accounts Payable | 1.53476 | 1.6141 | 1.68473 | 1.66763 | 1.81512 |
Accrued Expenses | 1.05726 | 2.32693 | 1.68645 | 1.86687 | 1.7253 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.74012 | 7.15037 | 7.28204 | 0.95976 | 0.78382 |
Other Current Liabilities, Total | 0.04662 | 0.08109 | 10.0662 | 10.0656 | 12.0414 |
Total Liabilities | 10.3939 | 11.1924 | 20.7454 | 21.5924 | 16.7115 |
Total Long Term Debt | 0 | 0 | 0 | 6.99489 | 0.30729 |
Long Term Debt | 0 | 0 | 6.99489 | 0.30729 | |
Other Liabilities, Total | 0.01508 | 0.01995 | 0.02606 | 0.03763 | 0.03863 |
Total Equity | 29.7942 | 20.4666 | 4.24614 | 8.99056 | 12.1401 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Common Stock | 0.00317 | 0.00284 | 0.0026 | 0.0026 | 0.00256 |
Additional Paid-In Capital | 127.35 | 110.683 | 97.4461 | 96.6219 | 94.9301 |
Retained Earnings (Accumulated Deficit) | -97.559 | -90.2193 | -93.2026 | -87.634 | -82.7926 |
Total Liabilities & Shareholders’ Equity | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
Total Common Shares Outstanding | 31.6984 | 28.4266 | 25.9632 | 25.9466 | 25.6236 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
Denarna sredstva iz poslovanja | -20.8744 | -6.38428 | -18.9193 | -13.1111 | -4.73111 |
Denarna sredstva iz poslovanja | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
Nedenarne postavke | 2.43593 | 2.48317 | 2.51194 | 1.61547 | 0.41231 |
Cash Taxes Paid | |||||
Denarna sredstva Plačane obresti | 0.22717 | 0.01397 | |||
Spremembe v obratnem kapitalu | -10.7535 | 10.807 | -0.28984 | 2.50737 | -0.0389 |
Denarna sredstva pri naložbenju | -1.61852 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
Kapitalski izdatki | -1.22658 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
Celotne druge postavke denarnih tokov pri naložbenju | -0.39194 | ||||
Denarna sredstva pri financiranju | 21.458 | 20.8648 | 13.5104 | 27.6177 | 6.60357 |
Izdaja (odplačilo) delnic, neto | 14.7299 | 20.8766 | 13.5104 | 27.6177 | 6.60357 |
Neto sprememba denarnih sredstev | -1.03498 | 14.2192 | -5.5756 | 14.4787 | 1.86222 |
Izdaja (odplačilo) dolga, neto | 6.72802 | -0.01186 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.33967 | -12.7784 | -15.7617 | -10.1931 | -5.35167 |
Cash From Operating Activities | -8.1844 | -20.8744 | -14.9978 | -9.90314 | -4.57385 |
Cash From Operating Activities | 0.07543 | 0.22156 | 0.14825 | 0.07524 | 0.03328 |
Non-Cash Items | 0.9352 | 2.43593 | 1.65033 | 1.30978 | 0.65691 |
Cash Interest Paid | 0.09559 | 0.22717 | 0.13184 | 0.07046 | 0.004 |
Changes in Working Capital | -1.85537 | -10.7535 | -1.03471 | -1.0951 | 0.08763 |
Cash From Investing Activities | -0.20766 | -1.61852 | -1.16507 | -0.64774 | -0.34432 |
Capital Expenditures | -0.17457 | -1.22658 | -1.16507 | -0.64774 | -0.34432 |
Cash From Financing Activities | 15.6465 | 21.458 | 9.16692 | 9.3559 | 1.45339 |
Financing Cash Flow Items | -0.08339 | 0 | |||
Issuance (Retirement) of Stock, Net | 15.8417 | 14.7299 | 2.28079 | 2.23408 | 1.53099 |
Issuance (Retirement) of Debt, Net | -0.11179 | 6.72802 | 6.88612 | 7.12182 | -0.0776 |
Net Change in Cash | 7.25442 | -1.03498 | -6.99596 | -1.19499 | -3.46478 |
Cash Taxes Paid | 0 | 0 | |||
Other Investing Cash Flow Items, Total | -0.0331 | -0.39194 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Grant (Stuart M) | Individual Investor | 14.2096 | 5132677 | 21753 | 2022-12-30 | LOW |
Eshelman (Fredric N) | Individual Investor | 4.4624 | 1611872 | -6963 | 2022-11-10 | LOW |
Ianchulev (Tsontcho M.D.) | Individual Investor | 3.3016 | 1192562 | -21316 | 2022-12-27 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5451 | 919322 | -8433 | 2022-12-31 | LOW |
Medical Strategy GmbH | Investment Advisor | 1.922 | 694259 | 0 | 2022-09-30 | LOW |
Avenue Capital Group | Investment Advisor/Hedge Fund | 1.5166 | 547807 | 547807 | 2022-12-31 | HIGH |
Mario (Ernest B) | Individual Investor | 1.0595 | 382706 | 6963 | 2021-11-17 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9314 | 336432 | 336432 | 2022-12-31 | LOW |
Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8721 | 315029 | 315029 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.7987 | 288500 | 24400 | 2022-12-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.72 | 260067 | 6056 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.2507 | 90568 | 14153 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2035 | 73517 | 11900 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1954 | 70581 | 1159 | 2022-12-31 | LOW |
Mather (Charles E IV) | Individual Investor | 0.1953 | 70544 | 22222 | 2022-06-16 | LOW |
Clasby (Jennifer G) | Individual Investor | 0.1842 | 66537 | 10835 | 2021-06-17 | |
Lee (Kenneth B Jr) | Individual Investor | 0.1787 | 64544 | 22222 | 2022-06-16 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.1326 | 47900 | 0 | 2022-12-31 | LOW |
Oak Family Advisors, LLC | Investment Advisor/Hedge Fund | 0.1276 | 46073 | -13113 | 2022-12-31 | MED |
BNY Mellon Asset Management | Investment Advisor | 0.1228 | 44374 | -1136 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Eyenovia, Inc. Company profile
O družbi Eyenovia, Inc.
Eyenovia, Inc. je oftalmološko podjetje v klinični fazi. Družba razvija nabor terapevtskih izdelkov, ki temeljijo na tehnologiji platforme MAP (microdose array print). Njegovo podjetje se osredotoča na pozno fazo razvoja mikrodoziranih zdravil za progresivno kratkovidnost, presbiopijo in mydriazo. Med kandidati za izdelke družbe so MydCombi, MicroPine in MicroLine. MydCombi je kombinirani izdelek v mikroobliki (fenilefrin-tropikamid) za farmakološko mydriazo (razširitev oči). MicroPine je lokalno zdravilo za zdravljenje progresivne kratkovidnosti, očesne bolezni očesnega ozadja, povezane s patološkim podaljševanjem osi in skleroretinalnim raztezanjem. MicroLine je kandidat, ki razvija mikrodozirano različico pilokarpina, oftalmološkega zdravila, ki lahko v odvisnosti od odmerka povzroči miozo ali krčenje zenice.
Industry: | Pharmaceuticals (NEC) |
295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com